TY - JOUR
T1 - Pulmonary Veno-Occlusive Disease Presenting as Congenital Heart Disease–Associated Pulmonary Hypertension
AU - Suzuki, Takanori
AU - Kawai, Satoru
AU - Tanaka, Satona
AU - Uchida, Hidetoshi
AU - Ukai, Hiromu
AU - Nomura, Yoji
AU - Katsuragawa, Hiroyuki
AU - Kawada, Jun ichi
AU - Yoshida, Shuichiro
N1 - Publisher Copyright:
© 2026 The Authors
PY - 2026/10/7
Y1 - 2026/10/7
N2 - Background: Pulmonary veno-occlusive disease (PVOD) is a rare cause of pulmonary hypertension rarely linked to congenital heart disease (CHD). Case Summary: An infant with a ventricular septal defect developed pulmonary hypertension. At 3 months, cardiac catheterization showed operable hemodynamics with preserved pulmonary vasoreactivity. Pulmonary artery banding was performed. Despite tadalafil, macitentan, and prostacyclin, pulmonary vascular resistance increased without pulmonary edema. Lung perfusion scintigraphy demonstrated perfusion defects, prompting transplantation. At 2 years and 10 months, he underwent bilateral lung transplantation with intracardiac repair. The explanted lungs demonstrated fibrous intimal thickening of pulmonary venules and hemosiderin deposition, indicating PVOD. Discussion: PVOD may coexist with CHD and mimic CHD-associated pulmonary arterial hypertension, without pulmonary edema during vasodilator therapy. Take-Home Messages: PVOD should be considered in children with CHD developing progressive pulmonary hypertension despite favorable hemodynamics and preserved vasoreactivity. The absence of pulmonary edema during vasodilator therapy does not exclude PVOD.
AB - Background: Pulmonary veno-occlusive disease (PVOD) is a rare cause of pulmonary hypertension rarely linked to congenital heart disease (CHD). Case Summary: An infant with a ventricular septal defect developed pulmonary hypertension. At 3 months, cardiac catheterization showed operable hemodynamics with preserved pulmonary vasoreactivity. Pulmonary artery banding was performed. Despite tadalafil, macitentan, and prostacyclin, pulmonary vascular resistance increased without pulmonary edema. Lung perfusion scintigraphy demonstrated perfusion defects, prompting transplantation. At 2 years and 10 months, he underwent bilateral lung transplantation with intracardiac repair. The explanted lungs demonstrated fibrous intimal thickening of pulmonary venules and hemosiderin deposition, indicating PVOD. Discussion: PVOD may coexist with CHD and mimic CHD-associated pulmonary arterial hypertension, without pulmonary edema during vasodilator therapy. Take-Home Messages: PVOD should be considered in children with CHD developing progressive pulmonary hypertension despite favorable hemodynamics and preserved vasoreactivity. The absence of pulmonary edema during vasodilator therapy does not exclude PVOD.
KW - lung transplantation
KW - pulmonary hypertension
KW - pulmonary veno-occlusive disease
KW - ventricular septal defect
UR - https://www.scopus.com/pages/publications/105048178342
UR - https://www.scopus.com/pages/publications/105048178342#tab=citedBy
U2 - 10.1016/j.jaccas.2026.109910
DO - 10.1016/j.jaccas.2026.109910
M3 - Article
AN - SCOPUS:105048178342
SN - 2666-0849
VL - 31
JO - JACC: Case Reports
JF - JACC: Case Reports
IS - 40
M1 - 109910
ER -